United States:
Should Prescription Drug Risks Be Limited In TV Commercials? The FDA Wants Your Opinion
27 February 2014
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
Our firm's
LSHI Group reported on an announcement by the Food and Drug
Administration (FDA) last week, asking for public input on a
proposed research study concerning whether the risks presented in
direct-to-consumer (DTC) prescription drug ads should be limited
solely to risks that are considered "serious and
actionable." While some say the current risk statements found
in TV ads are too long and result in, among other things, reduced
consumer comprehension, others believe the DTC ads do not provide
enough risk information. The deadline for feedback is April 21,
2014. For more information, read the
recent post on the
Health Industry Washington Watch blog.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Media, Telecoms, IT, Entertainment from United States
Hiring A Name, Image, And Likeness Agent
McLane Middleton, Professional Association
I am a student-athlete and I want to hire an agent to negotiate NIL contracts for me. Is there anything I should be aware of when hiring an NIL agent?
Carefully Examine Those TCPA Complaints!
Klein Moynihan Turco LLP
Last month, in Woodard v. Health Insurance Alliance ("HIA"), a judge for the United States District Court for the Eastern District of Illinois issued a useful decision for defendants...